N/A
Completed N=70
Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED
Source: ClinicalTrials.gov NCT01989130 ↗Enrolled (actual)
70
Serious AEs
0.0%
Results posted
Apr 2017
Primary outcomePrimary: Percentage of Participants Prescribed Antibiotic Treatment — 7.1; 5.7 percentage of 70 participants
Summary
The purpose of this study is to determine if immediate availability of GeneXpert® CT/NG test results reduces the overtreatment rate for ED patients with suspected gonorrhea or chlamydia and to assess changes in clinician management decisions with real-time test results.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Prescribed Antibiotic Treatment |
7.1; 5.7 | — |
| PRIMARY Health Utilization |
1; 1; 5; 2; 3; 0 | — |
| PRIMARY Healthcare Cost |
— | — |
| PRIMARY Resolution of Symptoms |
17; 10 | — |
Eligibility Criteria
Inclusion Criteria
- greater than 18 years
- clinical suspicion of CT/NG
- able to give informed consent
- willingness to wait for test result
Exclusion Criteria
- less than 18 years
- pregnancy
- prisoners
- unable to give informed consent
Data sourced from ClinicalTrials.gov (NCT01989130). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.